Sai Life Sciences becomes a signatory of the United Nations Gl... - 26 August 2021 18:52

HYDERABAD, India, Aug. 26, 2021 /PRNewswire-AsiaNet/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory] (CRO/ CDMO), today announced that it has become a signatory of...

  Athos Therapeutics Announces Research Collaboration with Cleve... - 25 August 2021 03:00

LOS ANGELES, Aug. 25, 2021 /PRNewswire-AsiaNet/ -- -- Athos to perform a molecular analysis of patient samples from the Cleveland Clinic Athos Therapeutics, Inc., a late preclinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patie...

  Study Confirms Viraleze Antiviral Nasal Spray Provides Protect... - 23 August 2021 23:19

MELBOURNE, Australia, Aug. 23, 2021 /PRNewswire-AsiaNet/ -- Melbourne biotech company Starpharma has announced the publication of new data demonstrating the capability of its Viraleze antiviral nasal spray to protect against SARS-CoV-2 in an animal challenge model of SARS-CoV-2 infection[1]. Viraleze admin...

  RedHill Biopharma Announces Two New U.S. Patents Covering Opag... - 23 August 2021 21:00

TEL AVIV, Israel and RALEIGH, N.C., Aug. 23, 2021 /PRNewswire-AsiaNet/ -- U.S. patents for opaganib combination for the treatment of Ebola virus disease provides patent protection until 2035 Opaganib's 475-patient global Phase 2/3 study in severe COVID-19 approaching completion with upcoming top-line results Opag...

  MedAlliance Announces Enrollment of First Patient in Erectile ... - 19 August 2021 08:00

NYON, Switzerland, Aug. 19 /PRNewswire-AsiaNet/ -- MedAlliance has announced enrollment of the first patient in an erectile dysfunction (ED) feasibility study with its sirolimus drug-eluting balloon [DEB]. This occurred at the University of Rome Tor Vergata, Italy, under the direction of the s...

  Sai Life Sciences opens new Discovery Biology facility at its ... - 18 August 2021 20:40

HYDERABAD, India, Aug. 18, 2021 /PRNewswire-AsiaNet/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=biology-facility] (CRO-CDMO), today announced the opening of a new biology fac...

  Sinopec Proves China's First 100-Billion-Cubic-Meter Natural G... - 17 August 2021 23:21

DEYANG, China, Aug. 17, 2021 /PRNewswire-AsiaNet/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec") has proved another 34.029 billion cubic meters of natural gas at the Zhongjiang Gas Field, bringing the total known natural gas reserves in the Sichuan Basin to 106.1 billion cubic mete...

  SINOMED announces the first commercial implantation and Europe... - 17 August 2021 21:00

TIANJIN, China, July 17, 2021 /PRNewswire-AsiaNet/-- SINOMED, a leading international medical device company, announced the first commercial implantation of the HT Supreme® Drug-Eluting Stent (DES) at University Hospital Galway in partnership with the National University of Ireland Galway (NUI Galwa...

  BioAgilytix to Purchase Australia-based 360biolabs(R) - 16 August 2021 20:00

DURHAM, N.C., Aug. 16, 2021 /PRNewswire-AsiaNet/ -- -- Highly complementary transaction will strengthen company's ability to support bioanalytical services across all stages, development capabilities and geographies BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laborato...

  Occlutech granted important conditional FDA approval for PFO S... - 16 August 2021 16:00

SCHAFFHAUSEN, Switzerland, Aug. 16, 2021 /PRNewswire-AsiaNet/ -- Occlutech Holding AG ("Occlutech"), one of the world's leading providers of minimally invasive structural heart disease devices, announces the conditional U.S. Food and Drug Administration ("FDA") approval of its Investigational Device Exemption (...